PrEP via novel mechanisms of delivery: Into the unknown
mercredi 27 janvier 2021
•
OA04
•
17h30
>
18h30
•
PrEP via novel mechanisms of delivery: Into the unknown
•
Live channel 2
17h30
•
OA04.01
•
User assessment of a microarray patch for HIV PrEP and as a multipurpose prevention technology for HIV and pregnancy prevention: perspectives from Uganda and South Africa
Voir l'abstract
17h38
•
OA04.02
•
High protection against vaginal SHIV infection in macaques by a biodegradable implant releasing tenofovir alafenamide
Voir l'abstract
17h46
•
OA04.03
•
Distribution of long-acting (LA) cabotegravir (CAB) in plasma, mucosal tissues, and associated fluids after a single ultrasound-guided intramuscular (IM) injection in healthy adult participants
Voir l'abstract
17h54
•
OA04.04
•
Design and testing of a cabotegravir reservoir implant for HIV prevention
Voir l'abstract
18h02
•
OA04.05LB
•
Trial design, enrollment status, demographics, and pharmacokinetics (PK) data from a blinded interim analysis from a phase 2a trial of Islatravir once monthly (QM) for HIV pre-exposure prophylaxis (PrEP)
Voir l'abstract
18h10
•
OA04.06
•
Live Q&A
Voir l'abstract
|